( en | de | ru )

 

Disambiguation

From post

копироватьудалитьдобавить публикацию в буфер
Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.

, , , , , , , , и . Clin Cancer Res, 14 (20): 6590--6601 (октября 2008)
DOI: 10.1158/1078-0432.CCR-07-4377

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

Barbara Hero

Hero Landmann

Hero Brahms

Hero Brahms

Hero Janßen

 

Другие публикации лиц с тем же именем

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers., , , , , , , , , и 27 other автор(ы). Clin Cancer Res, 21 (8): 1904-1915 (апреля 2015)Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome., , , , , , , , , и . Genes Chromosomes Cancer, 45 (12): 1130--1142 (декабря 2006)Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease., , , , , , , , , и 1 other автор(ы). Cancer Lett, 250 (2): 250--267 (июня 2007)High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma., , , , , , , , , и 8 other автор(ы). Clin Cancer Res, 17 (15): 5082--5092 (августа 2011)Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR., , , , , , , , и . Clin Cancer Res, 14 (20): 6590--6601 (октября 2008)IT Infrastructure for Merging Data from Different Clinical Trials and Across Independent Research Networks., , , , , , , , , и . MIE, том 228 из Studies in Health Technology and Informatics, стр. 287-291. IOS Press, (2016)Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers, , , , , , , , , и 27 other автор(ы). Clinical Cancer Research, (сентября 2014)Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas., , , , , , , , , и 4 other автор(ы). Genome Biol, 9 (10): R150 (2008)Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome., , , , , , , , , и . Clin Cancer Res, 12 (17): 5118--5128 (сентября 2006)Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification., , , , , , , , , и 4 other автор(ы). J Clin Oncol, 24 (31): 5070--5078 (ноября 2006)